Transcranial magnetic stimulation (TMS) is one of the newer treatments available to Veterans to help alleviate symptoms of depression. Using fMRI, EEG, and blood based markers of neurogenesis, this group of studies aims to explore whether we can predict who will benefit most from this treatment modality.

Through the use of TMS, we aim to explore alternative stimulation locations which could mitigate or slow cognitive changes associated with mild cognitive impairment and Alzheimer's disease in older adults.

As we age, our bodies have encountered a variety of experiences (good and bad) which impact our ability to fight off illness. Using state of the art statistical analysis of archived health study data, we assess how different illnesses impact late life cognition.